Literature DB >> 20705113

Myeloid-derived suppressor cells: natural regulators for transplant tolerance.

Peter Boros1, Jordi C Ochando, Shu-Hsia Chen, Jonathan S Bromberg.   

Abstract

Myeloid derived suppressor cells (MDSC) contribute to the negative regulation of immune response in cancer patients. This review summarizes results on important issues related to MDSC biology, including expansion and activation of MDSC, phenotype, and subsets as well pathways and different mechanisms by which these cells exert their suppressive effect. Recent observations suggesting that MDSC may have roles in transplant tolerance are presented. Although therapeutic targeting and destruction of MDCS is of primary interest in cancer patients, in transplantation it will instead be necessary to induce, expand, and activate these cells; thus current possibilities for in vitro generation of MDSC are also discussed.
Copyright © 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20705113      PMCID: PMC3713408          DOI: 10.1016/j.humimm.2010.08.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  80 in total

1.  Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.

Authors:  Naoki Umemura; Masanao Saio; Tatsuhiko Suwa; Yusuke Kitoh; Juncheng Bai; Kenichi Nonaka; Guan-Feng Ouyang; Makoto Okada; Margit Balazs; Roza Adany; Toshiyuki Shibata; Tsuyoshi Takami
Journal:  J Leukoc Biol       Date:  2008-02-19       Impact factor: 4.962

2.  Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.

Authors:  Anne-Sophie Dugast; Thomas Haudebourg; Flora Coulon; Michèle Heslan; Fabienne Haspot; Nicolas Poirier; Romain Vuillefroy de Silly; Claire Usal; Helga Smit; Bernard Martinet; Pamela Thebault; Karine Renaudin; Bernard Vanhove
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

Review 3.  Tumor escape mechanism governed by myeloid-derived suppressor cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

4.  Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.

Authors:  Pratima Sinha; Chinonyerem Okoro; Dirk Foell; Hudson H Freeze; Suzanne Ostrand-Rosenberg; Geetha Srikrishna
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

Authors:  Lydia A Haile; Reinhard von Wasielewski; Jaba Gamrekelashvili; Christine Krüger; Oliver Bachmann; Astrid M Westendorf; Jan Buer; Roland Liblau; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  Gastroenterology       Date:  2008-06-12       Impact factor: 22.682

6.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

Authors:  Kiavash Movahedi; Martin Guilliams; Jan Van den Bossche; Rafael Van den Bergh; Conny Gysemans; Alain Beschin; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Blood       Date:  2008-02-13       Impact factor: 22.113

7.  A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Authors:  Bastian Hoechst; Lars A Ormandy; Matthias Ballmaier; Frank Lehner; Christine Krüger; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

8.  Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.

Authors:  James H Finke; Brian Rini; Joanna Ireland; Patricia Rayman; Amy Richmond; Ali Golshayan; Laura Wood; Paul Elson; Jorge Garcia; Robert Dreicer; Ronald Bukowski
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

9.  Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.

Authors:  Wei Zhang; Siyuan Liang; Juan Wu; Anatolij Horuzsko
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

10.  Subsets of myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Je-In Youn; Srinivas Nagaraj; Michelle Collazo; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

View more
  25 in total

Review 1.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice.

Authors:  Valorie L Chiasson; Kelsey R Bounds; Piyali Chatterjee; Lochana Manandhar; Abhinandan R Pakanati; Marcos Hernandez; Bilal Aziz; Brett M Mitchell
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

3.  Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Authors:  Su Ji Jeong; John G Cooper; Igal Ifergan; Tammy L McGuire; Dan Xu; Zoe Hunter; Sripadh Sharma; Derrick McCarthy; Stephen D Miller; John A Kessler
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

4.  Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10.

Authors:  Melba Muñoz; Ahmed N Hegazy; Tobias M Brunner; Vivien Holecska; Roman M Marek; Anja Fröhlich; Max Löhning
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

5.  Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury.

Authors:  Jonghyuck Park; Yining Zhang; Eiji Saito; Steve J Gurczynski; Bethany B Moore; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

6.  The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.

Authors:  Ching-Chuan Hsieh; Hong-Shiue Chou; Horng-Ren Yang; Feng Lin; Sumantha Bhatt; Jie Qin; Lianfu Wang; John J Fung; Shiguang Qian; Lina Lu
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

7.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

8.  C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants.

Authors:  Jie Qin; Yusuke Arakawa; Miwa Morita; John J Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

9.  Relationship of Transforming Growth Factor-βl and Arginase-1 Levels with Long-term Survival after Kidney Transplantation.

Authors:  Xiao-Xiao Du; Yu-Liang Guo; Min Yang; Yan Yu; Sheng Chang; Bin Liu; Lan-Jun Cai; Zhong-Hua Klaus Chen
Journal:  Curr Med Sci       Date:  2018-06-22

Review 10.  Regulatory myeloid cells in transplantation.

Authors:  Brian R Rosborough; Dàlia Raïch-Regué; Heth R Turnquist; Angus W Thomson
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.